News on Medial

Related News

Exclusive: Stanza Living secures debt from Alteria and Innoven Capital

EntrackrEntrackr · 7d ago
Exclusive: Stanza Living secures debt from Alteria and Innoven Capital
Medial

Exclusive: Stanza Living secures debt from Alteria and Innoven Capital Managed accommodation provider Stanza Living secured Rs 60 crore (approximately $7 million) in debt funding from Alteria Capital and Innoven Capital. Previously, Stanza Living raised Rs 110 crore ($13 million) in a bridge round led by Alpha Wave, as exclusively reported by Entrackr. The Stanza Living’s board issued 6,000 non-convertible debentures at a face value of Rs 1,00,000 each to raise the above-mentioned amount, its regulatory filing accessed from the Registrar of Companies (RoC) shows. Alteria Capital invested Rs 35 crore ($4.1 million) while Innoven Capital contributed with Rs 25 crore ($2.9 million) in the round. Founded in 2017, Stanza Living is a managed accommodation startup that offers hassle-free living for students and young professionals moving to new cities. The company claims to have over 75,000 beds across 24 cities in India. The Delhi-based startup has raised over $240 million to date across multiple debt and equity rounds from investors such as Alpha Wave, Peak XV Partners, Accel, and Z47, according to startup data intelligence platform TheKredible. The Accel-backed company is yet to file its financials for FY24 and FY25. In FY23, its revenue rose to Rs 442 crore from Rs 115 crore in FY22, while losses widened 18.71% to Rs 495 crore during the same period. Stanza Living competes with Your-Space, which recently raised Rs 70 crore in debt, and Truliv, which entered into a strategic equity partnership with Bennett, Coleman and Company Limited (BCCL). Other competitors include Colive, Settl, Union Living, and Coho.

Decoding Ultrahuman’s Series B: Deepinder Goyal pumped in $10 Mn

EntrackrEntrackr · 1y ago
Decoding Ultrahuman’s Series B: Deepinder Goyal pumped in $10 Mn
Medial

Wearable tech startup Ultrahuman had raised $35 million in a mix of debt and equity in its Series B round led by Deepinder Goyal and existing investors Blume Ventures, Steadview Capital, Nexus VP, and Alpha Wave. While the company didn’t disclose about Goyal leading the round, Entrackr has decoded his investment along with others including Ultrahuman’s cap table and valuation through its regulatory filings. The board at Ultrahuman passed a special resolution to allot 6,979 Series B CCPS at an issue price of Rs 3,00,170 each to raise Rs 209.4 crore or $25 million, its regulatory filing accessed from the Registrar of Companies shows. Zomato’s co-founder Goyal led the round with Rs 83 crore while Alpha Wave and Blume Ventures infused Rs 66.34 crore and 29.86 crore, respectively. Nexus Venture Partners, Steadview Capital, and Panthera Capital participated with Rs 12.42 crore, Rs 13.77 crore, and Rs 4.14 crore. At the time of announcement, Ultrahuman said that the Series B round consisted of $25 million equity and $10 million debt. It’s worth noting that Ultrahuman’s co-founders Mohit Kumar and Vatsal Singhal sold their first startup Runnr to Zomato in September 2017. Zomato leveraged Runnr which merged with Mumbai-based TinyOwl to raise its own delivery fleet. Ultrahuman has raised over $60 million, including $35 million in Series B and $17.5 million in Series A in October 2022. As per TheKredible estimates, the company has been valued at around Rs 1,039 crore or $125 million (post-allotment of Series B round). Following the fresh proceeds, Nexus emerged as the largest external stakeholder with 17.26% followed by Alpha Wave’s 14.8% stake. Goyal holds 8.58% of the company. The company also has an ESOP pool of around 10.84% Head to TheKredible for the complete shareholding pattern. Ultrahuman is a self-quantification platform that provides a smart ring called Ring Air, a glucose monitoring wearable M1 Live, and a blood testing product called Blood Vision, among others. Ultrahuman demonstrated impressive financial performance in FY23 and its operating revenue flew 4X to Rs 30 crore. At the same time, the company’s losses grew only 21.4% to Rs 71 crore during the same period. Levels Health, Super Sapiens and Oura are the global peers of Ultrahuman.

After securing PA license, Mswipe raises $20 Mn in Alpha Wave-led round

EntrackrEntrackr · 1y ago
After securing PA license, Mswipe raises $20 Mn in Alpha Wave-led round
Medial

Mswipe Technologies has closed a $20 million growth equity round led by Alpha Wave Global along with the participation of existing investors. The digital payments company recently received a payment aggregator (PA) license from the Reserve Bank of India (RBI). It’s worth noting that the funding has come after a gap of almost five years for the Mumbai-based company. To date, the startup has raised over $125 million from several marquee investors, including Matrix Partners, B Capital, DSG Consumer Partners, Epiq Capital, UC-RNT, and Ola. Fresh capital will help Mswipe expand its merchant payment network, and further strengthen product development and technological infrastructure, the company said in a press release. Mswipe provides a host of offline and online payment acceptance solutions, including point-of-sale devices, UPI, quick response codes and payment links to help offline merchants receive payments digitally. As mentioned above, Mswipe was recently granted the PA licence, which now enables the firm to provide full-stack payment technology providing omni-channel solutions. The PA license solidifies the company’s objective to enhance its suite of offerings while delivering secure payment technology to banking partners, enterprises, and merchants across categories, Mswipe had said in a statement. Mswipe has now joined the likes of Zomato, Decentro, Zoho, Juspay, Razorpay, Cashfree, Open and Enkash which recently received a nod from RBI to operate as an online payment aggregation platform. As per startup data intelligence platform TheKredible, Mswipe’s revenue from operations increased 13.69% to Rs 274 crore in FY23 compared to Rs 241 crore in FY22. Its losses contracted by 45.36% to Rs 49 crore in FY23 from Rs 90 crore in FY22. The company claims that it has been profitable at an EBITDA level for the last five quarters.

Download the medial app to read full posts, comements and news.